<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1995-4484-2002-757</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-894</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>ТОКСИЧЕСКОЕ ПОРАЖЕНИЕ ПЕЧЕНИ СУЛЬФАСАЛАЗИНОМ</article-title><trans-title-group xml:lang="en"><trans-title>SULFASALAZINE INDUCED TOXIC HEPATIC INJURY</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Koreneva</surname><given-names>I N</given-names></name><name name-style="western" xml:lang="en"><surname>Koreneva</surname><given-names>I N</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Mouraviev</surname><given-names>Ju V</given-names></name><name name-style="western" xml:lang="en"><surname>Mouraviev</surname><given-names>Ju V</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Yevsikova</surname><given-names>M D</given-names></name><name name-style="western" xml:lang="en"><surname>Yevsikova</surname><given-names>M D</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib></contrib-group><pub-date pub-type="collection"><year>2002</year></pub-date><pub-date pub-type="epub"><day>15</day><month>02</month><year>2002</year></pub-date><volume>40</volume><issue>1</issue><issue-title>№1 (2002)</issue-title><fpage>73</fpage><lpage>74</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Koreneva I.N., Mouraviev J.V., Yevsikova M.D., 2002</copyright-statement><copyright-year>2002</copyright-year><copyright-holder xml:lang="ru">Koreneva I.N., Mouraviev J.V., Yevsikova M.D.</copyright-holder><copyright-holder xml:lang="en">Koreneva I.N., Mouraviev J.V., Yevsikova M.D.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/894">https://rsp.mediar-press.net/rsp/article/view/894</self-uri><abstract><p>Описана 31 -летняя больная РА, у которой на 10-15 день лечение сульфасалазином в дозе 1.5 г/кг развилась лекарственная реакция в виде лихорадки, лимфаденопатии, миалгий, расширенных геморрагических высыпаний и клиники токсического гепатита с резким повышением печёночных ферментов. Отмена препарата и применение ГКС в/в и пер ос в течение месяца привело к ликвидации всех признаков тяжёлой лекарственной реакции.</p></abstract><kwd-group xml:lang="ru"><kwd>сульфасалазин. гепатит</kwd><kwd>РА</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Sulphasalazine</kwd><kwd>henatitis</kwd><kwd>RA</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">&lt;div&gt;&lt;p&gt;Машковский М.Д. Лекарственные средства: В 2-х томах, Т.2.-10-е изд.стер. М., Медицина. 1987. 576.&lt;/p&gt;&lt;p&gt;МКБ - Международная статистическая классификация болезнен и проблем, связанных со здоровьем: 10-и пересмотр. T.I. ВОЗ. Женева, 1995. 3- Barraso N. Leo Е„ Guil A. el al. Non-immunoallergic hepatotoxicity due mesalazine. Gaslroenterol.Hepatol., 1999, 22. 4,176-179&lt;/p&gt;&lt;p&gt;Besuard М. Debray D. Durand P. et al. Fulminant hepatitis in two children treated with sulfasalazine for Crohn disease Arch.Pediatr. 1999. 6. 6. 643-646.&lt;/p&gt;&lt;p&gt;Boyer D.L., Li B.U. Fyda J.N., Friedman R.A. Sulfasalazine- induced hepatotoxicity in children with inflammatory bowel disease. J. Pediater. Gastroenterol, Nutr., 1989, 8, 4. 528-532,&lt;/p&gt;&lt;p&gt;Callen J.P., Soderstorm R.M., Granulematous hepatitis associated with salicylazosulfapyridine therapy. South. Med. J., 1978, 71, 9. 1159-1160.&lt;/p&gt;&lt;p&gt;Chester A.C. Diamond L.H., Schreiner G.E. Hypersensitivity to salicylazosulfapyridine renal and hepatic toxic reactions. Arch.Intern.Med., 1978. 138. 7. 1138-1139.&lt;/p&gt;&lt;p&gt;Farr М., Simmons D.P. Bacon P.A. Raised serum alkaline phosphatase and aspartate transaminase levels in two rheumatoid patiens treated with sulphasalazine. Ann.Rhcum.Dis., 1985. 44. II. 798-800.&lt;/p&gt;&lt;p&gt;Gremse D.A., Bancroft J., Moyer M.S. Sulfasalazine hypersensitivity with hepatotoxicity. trombocytopenia.and ervtroid hyperplasia. J. Pediatr. Gaslroenterol. Nutr. 1989. 9. 2, 261 - 263.&lt;/p&gt;&lt;p&gt;Gulley R.M., Mirza A-, Kelley C.E. Hepatotoxicity of salicy- lazosulfapyridine: a case report and review of the literature. Am.J.Gastrointestinal., 1979. 75, 5. 561-564.&lt;/p&gt;&lt;p&gt;Haines J.DJr. Hepatotoxicity after treatment with sulfasalazine. Postgrad. Med., 1986. 79. 6. 193-4. 197-198.&lt;/p&gt;&lt;p&gt;Kanner R.S., Tedesco F.J. Kaiser M.H. Azulfidine (sulfasalazine) induced hepatic injury. Am. J. Dig. Dis. 1978,.23, 10, 956-958.&lt;/p&gt;&lt;p&gt;Mihas A.A. Goldenberg D.J. Slaughter R.l. Sulfasalazine toxic reactions, hepatitis, fever and skin rash with hypoconiplemenl- mia and immune complexes. JAMA. 1978. 239. 24. 25902591.&lt;/p&gt;&lt;p&gt;Ribe J., Benkov K.J. Thung S.N. et al. Fatal massive hepatic necrosis:a probable hypersensitivity reaction to sulfasalazine. Am.J.Gastroenterol., 1986, 81. 3. 205-208.&lt;/p&gt;&lt;p&gt;Rubin R. Sulfasalazine-induced fulminant hepatic failure and necrotizing pancreatitis. Am.J.Gastroenlerol. 1994. 89. 5, 789791.&lt;/p&gt;&lt;p&gt;Schoonjans R. Mast A., Van den Abeelc G- et al. Sulfasalazine-associated encephalopathy in a patient with Crohn's disease, Am.J.Gastroenterol., 1993, 88. 10, 1759-1763.&lt;/p&gt;&lt;p&gt;Senturk Т. Aydintung A.O., Durzun N. Tokgoz G. Sezures and hepatotoxicity following sulphasalazine administration. Rheumatol.Int., 1997. 17. 2. 75-77, IS. Smith M.D., Gibson G.E. Rowland R. Combined hepatotoxic- ity and neurotoxicity following sulfasalazine administration. Aust. N. Z. J. Med., 1982. 12, 1. 76-80.&lt;/p&gt;&lt;p&gt;Sotolongo R.P., Neebe L.I., Rudzki C„ Ishak k.G. Hypersensitivity reaction to sulfasalazine with severe hepatotoxicity. Gastroenterol., 1978. 75, I, 95-99.&lt;/p&gt;&lt;p&gt;Tohyama M„ Yahata Y. Yasukawa M. el al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch. Dermatol. 1998, 134, 9. 1113-1117.&lt;/p&gt;&lt;/div&gt;&lt;br /&gt;</mixed-citation><mixed-citation xml:lang="en">&lt;div&gt;&lt;p&gt;Машковский М.Д. Лекарственные средства: В 2-х томах, Т.2.-10-е изд.стер. М., Медицина. 1987. 576.&lt;/p&gt;&lt;p&gt;МКБ - Международная статистическая классификация болезнен и проблем, связанных со здоровьем: 10-и пересмотр. T.I. ВОЗ. Женева, 1995. 3- Barraso N. Leo Е„ Guil A. el al. Non-immunoallergic hepatotoxicity due mesalazine. Gaslroenterol.Hepatol., 1999, 22. 4,176-179&lt;/p&gt;&lt;p&gt;Besuard М. Debray D. Durand P. et al. Fulminant hepatitis in two children treated with sulfasalazine for Crohn disease Arch.Pediatr. 1999. 6. 6. 643-646.&lt;/p&gt;&lt;p&gt;Boyer D.L., Li B.U. Fyda J.N., Friedman R.A. Sulfasalazine- induced hepatotoxicity in children with inflammatory bowel disease. J. Pediater. Gastroenterol, Nutr., 1989, 8, 4. 528-532,&lt;/p&gt;&lt;p&gt;Callen J.P., Soderstorm R.M., Granulematous hepatitis associated with salicylazosulfapyridine therapy. South. Med. J., 1978, 71, 9. 1159-1160.&lt;/p&gt;&lt;p&gt;Chester A.C. Diamond L.H., Schreiner G.E. Hypersensitivity to salicylazosulfapyridine renal and hepatic toxic reactions. Arch.Intern.Med., 1978. 138. 7. 1138-1139.&lt;/p&gt;&lt;p&gt;Farr М., Simmons D.P. Bacon P.A. Raised serum alkaline phosphatase and aspartate transaminase levels in two rheumatoid patiens treated with sulphasalazine. Ann.Rhcum.Dis., 1985. 44. II. 798-800.&lt;/p&gt;&lt;p&gt;Gremse D.A., Bancroft J., Moyer M.S. Sulfasalazine hypersensitivity with hepatotoxicity. trombocytopenia.and ervtroid hyperplasia. J. Pediatr. Gaslroenterol. Nutr. 1989. 9. 2, 261 - 263.&lt;/p&gt;&lt;p&gt;Gulley R.M., Mirza A-, Kelley C.E. Hepatotoxicity of salicy- lazosulfapyridine: a case report and review of the literature. Am.J.Gastrointestinal., 1979. 75, 5. 561-564.&lt;/p&gt;&lt;p&gt;Haines J.DJr. Hepatotoxicity after treatment with sulfasalazine. Postgrad. Med., 1986. 79. 6. 193-4. 197-198.&lt;/p&gt;&lt;p&gt;Kanner R.S., Tedesco F.J. Kaiser M.H. Azulfidine (sulfasalazine) induced hepatic injury. Am. J. Dig. Dis. 1978,.23, 10, 956-958.&lt;/p&gt;&lt;p&gt;Mihas A.A. Goldenberg D.J. Slaughter R.l. Sulfasalazine toxic reactions, hepatitis, fever and skin rash with hypoconiplemenl- mia and immune complexes. JAMA. 1978. 239. 24. 25902591.&lt;/p&gt;&lt;p&gt;Ribe J., Benkov K.J. Thung S.N. et al. Fatal massive hepatic necrosis:a probable hypersensitivity reaction to sulfasalazine. Am.J.Gastroenterol., 1986, 81. 3. 205-208.&lt;/p&gt;&lt;p&gt;Rubin R. Sulfasalazine-induced fulminant hepatic failure and necrotizing pancreatitis. Am.J.Gastroenlerol. 1994. 89. 5, 789791.&lt;/p&gt;&lt;p&gt;Schoonjans R. Mast A., Van den Abeelc G- et al. Sulfasalazine-associated encephalopathy in a patient with Crohn's disease, Am.J.Gastroenterol., 1993, 88. 10, 1759-1763.&lt;/p&gt;&lt;p&gt;Senturk Т. Aydintung A.O., Durzun N. Tokgoz G. Sezures and hepatotoxicity following sulphasalazine administration. Rheumatol.Int., 1997. 17. 2. 75-77, IS. Smith M.D., Gibson G.E. Rowland R. Combined hepatotoxic- ity and neurotoxicity following sulfasalazine administration. Aust. N. Z. J. Med., 1982. 12, 1. 76-80.&lt;/p&gt;&lt;p&gt;Sotolongo R.P., Neebe L.I., Rudzki C„ Ishak k.G. Hypersensitivity reaction to sulfasalazine with severe hepatotoxicity. Gastroenterol., 1978. 75, I, 95-99.&lt;/p&gt;&lt;p&gt;Tohyama M„ Yahata Y. Yasukawa M. el al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch. Dermatol. 1998, 134, 9. 1113-1117.&lt;/p&gt;&lt;/div&gt;&lt;br /&gt;</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
